3 reports

The company provides comprehensive range of tests that focus on molecular diagnostics, genetics, anatomical pathology, oncology, and women' s health.

  • Breast Cancer
  • Medical Device
  • Australia
  • United States
  • Genetic Technologies Limited

New data generated by Resverlogix has demonstrated that BET inhibition by apabetalone (RVX-##) has effects on multiple biological pathways that underlie disease pathology.

  • Breast Cancer
  • Cardiovascular Disease
  • Therapy
  • Australia
  • Product Initiative

CS-## acts on sphingosine ##-phosphate (S##P) receptor ##.

  • Breast Cancer
  • Cancer
  • Therapy
  • Australia
  • Daiichi Sankyo Company